About Fluidex Pharmaceuticals Private Limited
Data last updated:
Fluidex Pharmaceuticals Private Limited is a private limited company based in Kollam, Kerala, India. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 04 November 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U21004KL2013PTC035345.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors including Shuktha and Nagurao Venkateshwara Rao.
Its last annual general meeting (AGM) was held on 30 May 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Vijaya Krishna(Rajasthan House) Kannimel Cherry Maruthady P O, Kollam, Kerala, India – 691003.
As per the financials filed for FY 2024, the company reported a revenue of ₹78.35 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.05 Lakh (net margin 1.3%) and EBITDA of ₹1.89 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
The company has about 3 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Neonooa Business Solutions Private Limited. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neonooa.com.
CIN History of Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals has one previous CIN (Corporate Identification Number): U74140KL2013PTC035345. The current CIN is U21004KL2013PTC035345, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21004KL2013PTC035345 | Current |
| U74140KL2013PTC035345 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVijaya Krishna(Rajasthan House) Kannimel Cherry Maruthady P O, Kollam, Kerala, India – 691003
- IndustryTravel and Hospitality, Consumer Professional Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals operates one associated brand: Neonooa Business Solutions Private Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Business solutions for MSMEs in finance, administration, operations, IT, HR, and sales and marketing. | neonooa.com |
Business Activity of Fluidex Pharmaceuticals Private Limited
The main business activity of Fluidex Pharmaceuticals is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fluidex Pharmaceuticals Private Limited FY 2024 filings available
Fluidex Pharmaceuticals Private Limited reported revenue of ₹78.35 Lakh (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Fluidex Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 10% growth in the latest year. EBITDA rose 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Fluidex Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.89 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.05 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Fluidex Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fluidex Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shuktha | Director | 30 May 2025 | 1 Years 4 Months | Current |
| Nagurao Venkateshwara Rao | Director | 22 Feb 2025 | 1 Years 7 Months | Current |
| Ajay Kumar Sharma | Director | 22 Oct 2025 | 0 Years 11 Months | Current |
Peer Comparison of Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Pharmaceuticals, Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Divine Outfitters Private Limited | ₹78.45 Lakh (FY 2025) | •••• | •••• | 8.0% | •••• | New Edlhi, Delhi, India |
| Agshov Pharmaceuticals Private Limited | ₹78.43 Lakh (FY 2024) | •••• | •••• | 9.0% | •••• | North Twenty Four Pargana, West Bengal, India |
| Medchef Pharmaceuticals Private Limited | ₹78.43 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Bahrampur, Uttar Pradesh, India |
| Svap Pharmaceuticals Private Limited | ₹78.36 Lakh (FY 2025) | •••• | •••• | 41.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Rao Corporate Services Private Limited | ₹78.36 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Ahmedabad, Gujarat, India |
| Fluidex Pharmaceuticals Private Limited this company | ₹78.35 Lakh (FY 2024) | •••• | •••• | 10.0% | •••• | Kollam, Kerala, India |
| K2vr Analytical Research Private Limited | ₹78.25 Lakh (FY 2024) | •••• | •••• | 182.0% | •••• | Bengaluru, Karnataka, India |
| Sands Centre for Innovation and Testing Private Limited | ₹78.23 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Chennai, Tamil Nadu, India |
| Faith Pharmaceuticals Limited | ₹78.18 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Vindiata Consulting Private Limited | ₹78.13 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | Navi Mumbai, Maharashtra, India |
| Rietways Consultants Private Limited | ₹78.06 Lakh (FY 2025) | •••• | •••• | -20.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Fluidex Pharmaceuticals by revenue in the Consumer Services industry (Pharmaceuticals, Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Fluidex Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Fluidex Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals Private Limited has 4 board changes on record since 2020: 3 appointments and 1 cessation. The latest: Ajay Kumar Sharma was appointed as Director on 22 Oct 2025.
Credit Ratings, Litigation & Regulatory Alerts for Fluidex Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fluidex Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fluidex Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fluidex Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fluidex Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fluidex Pharmaceuticals Private Limited
Fluidex Pharmaceuticals is an active private limited company based in Kollam, Kerala, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 04 November 2013 (13+ years old) and is registered under CIN U21004KL2013PTC035345.
Fluidex Pharmaceuticals reported revenue of ₹78.35 Lakh for FY 2024 (up 10% YoY).
Fluidex Pharmaceuticals has 3 current directors:
- Shuktha - Director
- Nagurao Venkateshwara Rao - Director
- Ajay Kumar Sharma - Director
Fluidex Pharmaceuticals reported a net profit of ₹1.05 Lakh (net margin 1.3%) and EBITDA of ₹1.89 Lakh (EBITDA margin 2.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Fluidex Pharmaceuticals is 13% over three years. In the latest year (FY 2024) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Fluidex Pharmaceuticals is U21004KL2013PTC035345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fluidex Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Fluidex Pharmaceuticals was incorporated on 04 November 2013, making it 13+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Fluidex Pharmaceuticals by revenue are Divine Outfitters Private Limited, Agshov Pharmaceuticals Private Limited, Medchef Pharmaceuticals Private Limited, Svap Pharmaceuticals Private Limited, Rao Corporate Services Private Limited and 5 more, all in the Consumer Services industry (Pharmaceuticals, Professional Services).
Ajay Kumar Sharma was appointed as Director on 22 Oct 2025. Shuktha was appointed as Director on 30 May 2025. Nagurao Venkateshwara Rao was appointed as Director on 22 Feb 2025. Fluidex Pharmaceuticals has 4 board changes on record in total.
Fluidex Pharmaceuticals can be reached through the website neonooa.com. Its registered office is in Kollam, Kerala, India.